These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19120051)

  • 1. Alpha 2A-adrenergic receptor signaling underlies synergistic enhancement of ethanol-induced behavioral impairment by clonidine.
    Bender TS; Abdel-Rahman AA
    Alcohol Clin Exp Res; 2009 Mar; 33(3):408-18. PubMed ID: 19120051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential central NOS-NO signaling underlies clonidine exacerbation of ethanol-evoked behavioral impairment.
    Bender TS; Abdel-Rahman AA
    Alcohol Clin Exp Res; 2010 Mar; 34(3):555-66. PubMed ID: 20028349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic behavioral interaction between ethanol and clonidine in rats: role of alpha-2 adrenoceptors.
    Mao L; Abdel-Rahman AA
    J Pharmacol Exp Ther; 1996 Nov; 279(2):443-9. PubMed ID: 8930144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethanol selectively counteracts hypotension evoked by central I(1)-imidazoline but not alpha2-adrenergic receptor activation in spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Cardiovasc Pharmacol; 1998 Sep; 32(3):382-9. PubMed ID: 9733351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence for imidazoline (I1) receptor modulation of ethanol action on norepinephrine-containing neurons in the rostral ventrolateral medulla in conscious spontaneously hypertensive rats.
    Li G; Abdel-Rahman AA
    Alcohol Clin Exp Res; 2007 Apr; 31(4):684-93. PubMed ID: 17374048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-dependent inhibition of neuronal c-jun in the brainstem elicited by imidazoline I1 receptor activation: role in rilmenidine-evoked hypotension.
    Wang X; Li G; Abdel-Rahman AA
    Eur J Pharmacol; 2005 May; 514(2-3):191-9. PubMed ID: 15910806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence for functional imidazoline receptors on locus coeruleus neurons.
    Szabo B; Fröhlich R; Illes P
    Naunyn Schmiedebergs Arch Pharmacol; 1996 Apr; 353(5):557-63. PubMed ID: 8740150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative autoradiographic localization in rat brain of alpha 2-adrenergic and non-adrenergic I-receptor binding sites labelled by [3H]rilmenidine.
    King PR; Gundlach AL; Louis WJ
    Brain Res; 1995 Mar; 675(1-2):264-78. PubMed ID: 7796138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal norepinephrine responses of the rostral ventrolateral medulla and nucleus tractus solitarius neurons distinguish the I1- from the alpha2-receptor-mediated hypotension in conscious SHRs.
    Li G; Wang X; Abdel-Rahman AA
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):52-62. PubMed ID: 15965355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulatory effects of clonidine, cirazoline and rilmenidine on locus coeruleus noradrenergic neurones: possible involvement of imidazoline-preferring receptors.
    Pineda J; Ugedo L; García-Sevilla JA
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Aug; 348(2):134-40. PubMed ID: 7901773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained impairment of α2A-adrenergic autoreceptor signaling mediates neurochemical and behavioral sensitization to amphetamine.
    Doucet EL; Bobadilla AC; Houades V; Lanteri C; Godeheu G; Lanfumey L; Sara SJ; Tassin JP
    Biol Psychiatry; 2013 Jul; 74(2):90-8. PubMed ID: 23332355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atipamezole-precipitated clonidine withdrawal induces c-Fos expression in rat central nervous system.
    Stornetta RL; Grubb MC; Guyenet PG
    Brain Res; 1997 Aug; 764(1-2):81-92. PubMed ID: 9295196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
    Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desensitization to the behavioral effects of alpha 2-adrenergic agonists in rats.
    Hayashi Y; Guo TZ; Maze M
    Anesthesiology; 1995 Apr; 82(4):954-62. PubMed ID: 7717568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation by estrogen of alpha2-adrenergic and I1-imidazoline receptor-mediated hypotension in female rats.
    El-Mas MM; Abdel-Rahman AA
    J Appl Physiol (1985); 2004 Oct; 97(4):1237-44. PubMed ID: 15145918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol counteraction of I1-imidazoline but not alpha-2 adrenergic receptor-mediated reduction in vascular resistance in conscious spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Pharmacol Exp Ther; 1999 Feb; 288(2):455-62. PubMed ID: 9918545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic ethanol administration attenuates imidazoline I1 receptor- or alpha 2-adrenoceptor-mediated reductions in blood pressure and hemodynamic variability in hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    Eur J Pharmacol; 2004 Feb; 485(1-3):251-62. PubMed ID: 14757148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for the involvement of central I1 imidazoline receptor in ethanol counteraction of clonidine hypotension in spontaneously hypertensive rats.
    El-Mas MM; Abdel-Rahman AA
    J Cardiovasc Pharmacol; 2001 Sep; 38(3):417-26. PubMed ID: 11486246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selectivity of rilmenidine for I1-imidazoline-binding sites in rabbit proximal tubule cells.
    Gargalidis-Moudanos C; Parini A
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S59-62. PubMed ID: 8642808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine.
    Millan MJ; Lejeune F; Gobert A; Brocco M; Auclair A; Bosc C; Rivet JM; Lacoste JM; Cordi A; Dekeyne A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1206-22. PubMed ID: 11082458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.